Pulmonary Interstitial Emphysema (Macklin Effect), Quantitative Imaging Analysis and CytoKine Profiling to Predict Lung Frailty IN ARDS

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Barotrauma (pneumothorax, pneumomediastinum) is a well-described complication of Acute Respiratory Distress Syndrome (ARDS), especially in patients with coronavirus disease 2019 (COVID-19) (16.1% in COVID-19, and about 6% in non-COVID-19 ARDS). Macklin effect was recently discovered by our group as an accurate radiological predictor of barotrauma in COVID-19 ARDS; the Investigators also found that density histograms automatically extracted from chest CT images provide a reliable insight into lung composition . Since lung frailty is a major issue also in non-COVID-19 ARDS, the Investigators want to confirm the predictive role of Macklin effect also in this setting. In addition, the Investigators aim to explore inflammatory profiling to decipher different biological aspects of the same clinical issue. Finally, the Investigators want to develop a specific management algorithm for patients diagnosed, according to our findings, with a specific ARDS sub phenotype characterized by increased lung frailty

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Clinical and radiological signs of ARDS, according to Berlin criteria, requiring ICU admission;

• Obtain duly signed informed consent

• Availability of at least one chest CT scan during hospital stay

Locations
Other Locations
Italy
A.O.U. di Cagliari
NOT_YET_RECRUITING
Cagliari
IRCCS San Raffaele Scientific Institute
RECRUITING
Milan
A.O.U. Pisana
NOT_YET_RECRUITING
Pisa
Ospedale San Carlo
NOT_YET_RECRUITING
Potenza
Time Frame
Start Date: 2023-11-27
Estimated Completion Date: 2027-07
Participants
Target number of participants: 110
Treatments
Acute Respiratory Distress Syndrome
Patients with ARDS requiring or not requiring invasive ventilation
Sponsors
Leads: Università Vita-Salute San Raffaele

This content was sourced from clinicaltrials.gov